NCT01816321View on ClinicalTrials.gov

Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
InfertilityPoor Ovarian Response
Interventions
DRUG

Corifollitropin alfa

Corifollitropin alfa 150μg on day 2 of the menstrual cycle (stimulation day 1)

DRUG

recombinant FSH

recombinant FSH 300IU/daily from day 2 of the cycle (stimulation day 8)until day of ovulation triggering

DRUG

Ganirelix

Ganirelix 0.25mg/daily from day 7 of the cycle(stimulation day 6) until day of ovulation triggering

DRUG

hp HMG

hp HMG 300IU/daily from day 9 of the cycle (stimulation day 8)until day of ovulation triggering

Trial Locations (2)

1090

Universitair Ziekenhuis Brussel, Brussels

Unknown

University of Medicine and Pharmacy of Ho Chi Minh City, Ho Chi Minh City

All Listed Sponsors
collaborator

University of Medicine and Pharmacy at Ho Chi Minh City

OTHER

lead

Universitair Ziekenhuis Brussel

OTHER

NCT01816321 - Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial | Biotech Hunter | Biotech Hunter